Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in Acute Kidney Injury
NCT03401710Terminated
- Sponsor
- Saint Joseph's University
- Start
- Apr 2018
- Primary completion
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of erythropoietin in anemia (2 arms), sponsored by Saint Joseph's University. Primary endpoint: Number of red blood cell transfusions at 1 month. Started Apr 2018; status: terminated.
02
Drugs
erythropoietin
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03401710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03401710.